These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38856716)

  • 1. Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA Methylome.
    Li S; Li W; Liu B; Krysan K; Dubinett SM
    Cancer Res Commun; 2024 Jul; 4(7):1738-1747. PubMed ID: 38856716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
    Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
    Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.
    Qi J; Hong B; Wang S; Wang J; Fang J; Sun R; Nie J; Wang H
    Cancer Sci; 2024 Oct; 115(10):3426-3438. PubMed ID: 39038922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
    Chemi F; Pearce SP; Clipson A; Hill SM; Conway AM; Richardson SA; Kamieniecka K; Caeser R; White DJ; Mohan S; Foy V; Simpson KL; Galvin M; Frese KK; Priest L; Egger J; Kerr A; Massion PP; Poirier JT; Brady G; Blackhall F; Rothwell DG; Rudin CM; Dive C
    Nat Cancer; 2022 Oct; 3(10):1260-1270. PubMed ID: 35941262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
    Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
    J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
    Liu J; Dai L; Wang Q; Li C; Liu Z; Gong T; Xu H; Jia Z; Sun W; Wang X; Lu M; Shang T; Zhao N; Cai J; Li Z; Chen H; Su J; Liu Z
    Nat Commun; 2024 May; 15(1):3700. PubMed ID: 38697989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
    Patel KB; Padhya TA; Huang J; Hernandez-Prera JC; Li T; Chung CH; Wang L; Wang X
    Mol Carcinog; 2023 Apr; 62(4):493-502. PubMed ID: 36636912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.
    El Zarif T; Meador CB; Qiu X; Seo JH; Davidsohn MP; Savignano H; Lakshminarayanan G; McClure HM; Canniff J; Fortunato B; Li R; Banwait MK; Semaan K; Eid M; Long H; Hung YP; Mahadevan NR; Barbie DA; Oser MG; Piotrowska Z; Choueiri TK; Baca SC; Hata AN; Freedman ML; Berchuck JE
    Clin Cancer Res; 2024 Sep; 30(17):3798-3811. PubMed ID: 38912901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and integration of cell-free DNA signatures for detection of lung cancer.
    Xue R; Li X; Yang L; Yang M; Zhang B; Zhang X; Li L; Duan X; Yan R; He X; Cui F; Wang L; Wang X; Wu M; Zhang C; Zhao J
    Cancer Lett; 2024 Nov; 604():217216. PubMed ID: 39233043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
    Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
    FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation biomarkers discovered
    Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
    Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
    Magenheim J; Rokach A; Peretz A; Loyfer N; Cann G; Amini H; Moradi P; Nagaraju S; Sameer W; Cohen A; Fogel O; Kuint R; Abutbul A; Abu Rmeileh A; Karameh M; Cohen Goichman P; Wald O; Korach A; Neiman D; Fox-Fisher I; Moss J; Cohen D; Piyanzin S; Ben Ami R; Quteineh A; Golomb E; Shemer R; Glaser B; Kaplan T; Fridlender ZG; Dor Y
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35450968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
    Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
    Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection.
    Li Y; Liu B; Zhou X; Yang H; Han T; Hong Y; Wang C; Huang M; Yan S; Li S; Li J; Liu Y; Zhang E; Ni Y; Shen N; Chen W; Huang YS; Wu N
    JCO Precis Oncol; 2024 Jun; 8():e2400111. PubMed ID: 38976830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
    Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
    Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
    Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K
    Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
    Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
    Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury.
    You R; Quan X; Xia P; Zhang C; Liu A; Liu H; Yang L; Zhu H; Chen L
    Epigenetics; 2024 Dec; 19(1):2408146. PubMed ID: 39370847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.